Primary Myelofibrosis: Clinical Trials

1 trial for Primary Myelofibrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Primary Myelofibrosis: new trials by email Literature Review of Primary Myelofibrosis trials Research Report on Primary Myelofibrosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Exploratory Phase II Study of INC424 Patients With Primary Myelofibrosis (PMF) or Post Polycythaemia Myelofibrosis (PPV MF) or Post Essential Thrombocythaemia Myelofibrosis (PET-MF)
INC424 - Primary Myelofibrosis (PMF), Post Polycythaemia Myelofibrosis (PPV MF)
Phase 4CompletedNovartis Pharmaceuticals482012-05-012015-03-03

Narrower conditions

Blood Coagulation Disorders (1)  ·  Blood Platelet Disorders (1)  ·  Bone Marrow Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Myeloproliferative Disorders (1)  ·  Polycythemia (1)  ·  Thrombocythemia, Essential (1)  ·  Thrombocytosis (1)

Broader conditions

Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)

Interventions

ruxolitinib (1)

Sponsors

Novartis Pharmaceuticals (1)

Countries

United Kingdom (1)